FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

The FDA approved a supplemental Biologics License Application for BENLYSTA (belimumab) by GlaxoSmithKline LLC, resulting in an updated indication/label for the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BENLYSTA (belimumab)

Snippet

SUPPL AP for BENLYSTA (BELIMUMAB)